Keywords: astra, licence, osteoporosis, treatment, allelix, ab, obtained

Astra Licence Osteoporosis Treatment From Allelix

Article | 24 June 1996

- Astra AB has obtained the rights to Allelix Biopharmaceuticals' ALX1-11 (recombinant human parathyroid hormone) for the treatment of osteoporosis. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Antihemophilic Factor

Recombinant

Coagulation Factor VIIa

Go to drug listing